Trademark: 86944227
Word
ONGAVIA
Status
Dead
Status Code
606
Status Date
Monday, November 12, 2018
Serial Number
86944227
Mark Type
4000
Filing Date
Thursday, March 17, 2016
Published for Opposition
Tuesday, August 16, 2016
Abandoned Date
Monday, November 12, 2018

Trademark Owner History
Warner Chilcott Company, LLC - Owner At Publication

Classifications
5 Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines affecting sensory organs; Pharmaceuticals and medicines affecting the central nervous system; Pharmaceuticals and medicines affecting urogenital organs; Pharmaceuticals and medicines affecting circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceuticals used in connection with anti-aging, the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, facial aesthetic surgery, facial aesthetic reconstruction, breast aesthetics; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma and decongestant formulations; sterile ointments; ocular wetting solutions, artificial tears and formulations for the treatment of minor ocular inflammations and allergic conditions; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lighteners; Pharmaceuticals and cosmeceuticals, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body

Trademark Events
Dec 13, 2018
Undeliverable Mail - No Action Taken
Nov 13, 2018
Abandonment Notice Mailed - No Use Statement Filed
Nov 12, 2018
Abandonment - No Use Statement Filed
Jun 12, 2018
Notice Of Approval Of Extension Request E-Mailed
Jun 11, 2018
Extension 3 Granted
Apr 11, 2018
Extension 3 Filed
Jun 11, 2018
Case Assigned To Intent To Use Paralegal
May 24, 2018
Undeliverable Mail - No Action Taken
May 15, 2018
Teas Change Of Correspondence Received
May 16, 2018
Assigned To Examiner
May 15, 2018
Notice Of Revival - E-Mailed
May 15, 2018
Extension Received With Teas Petition
May 15, 2018
Petition To Revive-Granted
May 15, 2018
Teas Petition To Revive Received
May 14, 2018
Abandonment Notice Mailed - No Use Statement Filed
May 14, 2018
Abandonment - No Use Statement Filed
Sep 28, 2017
Notice Of Approval Of Extension Request E-Mailed
Sep 26, 2017
Extension 2 Granted
Sep 26, 2017
Extension 2 Filed
Sep 26, 2017
Teas Extension Received
Apr 5, 2017
Notice Of Approval Of Extension Request E-Mailed
Apr 3, 2017
Extension 1 Granted
Apr 3, 2017
Extension 1 Filed
Apr 3, 2017
Teas Extension Received
Oct 11, 2016
Noa E-Mailed - Sou Required From Applicant
Aug 16, 2016
Official Gazette Publication Confirmation E-Mailed
Aug 16, 2016
Published For Opposition
Jul 27, 2016
Notification Of Notice Of Publication E-Mailed
Jul 12, 2016
Approved For Pub - Principal Register
Jun 27, 2016
Assigned To Examiner
Mar 22, 2016
New Application Office Supplied Data Entered In Tram
Mar 21, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24